UtherTirzepatide
Ordered Tirzepatide from Uther? Mail in a sample (US only) and let us test it for free.
Test my supplyUther's Tirzepatide record is pulled down by the most recent actual test: identity failed, with 0% purity and 0 mg found. Earlier results were mostly clean, so the key issue is a late severe break rather than steady weakness.
We investigated who actually operates Uther — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Uther rows.
Cancel anytime
Ordered Tirzepatide from Uther? Mail in a sample (US only) and let us test it for free.
Test my supplyAbout Uther test results from Finnrick
Uther is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 14 peptides and 100 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Uther peptides in this dataset are BPC-157 (11 tests) and CJC-1295 (6 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 100 recent tests.
Ordered Tirzepatide from Uther? Mail in a sample (US only) and let us test it for free.
Test my supply